Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: s/p podiatry surgery and need for insulin drip major surgical or invasive procedure: : right charcot reconstruction history of present illness: 47 m c poorly controlled type ii dm on insulin and complicated by peripheral neuropathy who presented for r charcot joint reconstruction. had approx. 400 cc ebl during surgery. intraop had blood sugars in 300 range. postop had blood sugars > 400 and required insulin drip. transferred to for management of insulin drip. in initially had blood sugar greater than could be picked up by monitor. bolused 10 u regular insulin and continued on regular insulin drip at 10u/hr. past medical history: dm2 - last hgba1c 12 in . complicated by peripheral neuropathy. no hx retinopathy or nephropathy (cr 1.1-1.6 range, nl alb/cre urine ratio ) htn pvd - ? normal arterial hemodynamics hep b - hep b surface ab + genital herpes social history: sh: lives c wife & 8 kids, works at housekeeping, smokes pipe 4xd, etoh 4-5 drinks weekend, 1-2 drinks each weekday family history: mother c dm physical exam: vs- 95.9, 67-80, 95-122/61-75, 15-18, 100%ra heent- op clear, mmm lungs- cta heart- s1, s2, no murmurs abd- soft, nd, nt, bs+ ext- r foot c large metallic brace; can move r toes, states that he can feel light touch over r foot, capillary refill somewhat delayed over r foot. 2+ popliteal pulses b/l. pertinent results: 04:12pm hgb-13.7* calchct-41 04:12pm glucose-297* lactate-2.6* na+-135 k+-4.8 cl--103 08:06pm freeca-1.17 08:06pm hgb-13.3* calchct-40 08:06pm glucose-416* 08:06pm type- ph-7.38 intubated-intubated 08:22pm freeca-1.14 08:22pm hgb-13.1* calchct-39 08:22pm type-art temp-37 rates-/8 tidal vol-800 o2-50 po2-133* pco2-41 ph-7.38 total co2-25 base xs-0 intubated-intubated vent-controlled 09:15pm plt count-193 09:15pm wbc-8.5 rbc-4.22* hgb-11.6* hct-33.4* mcv-79* mch-27.6 mchc-34.8 rdw-14.2 09:15pm calcium-8.1* magnesium-1.7 09:19pm freeca-1.11* 09:19pm hgb-11.3* calchct-34 09:19pm glucose-358* lactate-4.4* na+-135 k+-3.9 cl--109 09:19pm type-art temp-37 po2-154* pco2-37 ph-7.35 total co2-21 base xs--4 intubated-not intuba 11:57pm plt count-171 11:57pm wbc-12.4* rbc-4.03* hgb-10.9* hct-30.9* mcv-77* mch-27.1 mchc-35.4* rdw-13.6 11:57pm calcium-8.1* phosphate-3.4# magnesium-1.7 11:57pm glucose-404* urea n-23* creat-1.3* sodium-138 potassium-4.5 chloride-107 total co2-19* anion gap-17 brief hospital course: : the patient was admitted to the s/p podiatric surgery with hyperglycemia. he was placed on an insulin drip, and his blood sugars became well controlled. he required as much as 30 units of insulin/hour. he was seen by , who recommended starting glargine and an insulin sliding scale. the first glargine dose tried was 20 units. this resulted in poorly controlled sugars, and so his dose was increased to 50 units. 50 units of glargine and a riss worked well to control his blood sugars as well 1000 metformin . the patient reports that his home insulin dose was 5 nph . it is felt on his transfer that this is inadequate, given his documented aic of 12 and hyperglecmia seen as an inpatient. he was transfered to the floor with stable vital signs and podiatry following. a/p: 47 m c uncontrolled type ii dm on insulin presents for hyperglycemia requiring insulin drip postoperatively. . 1. hyperglycemia: pt was transitioned to glargine 50u at breakfast w/iss, metformin 1gm . he tolerated pos well with fs range 150-190s. given recent stress response to surgery sugars may be better controlled once he recovers from procedure. . 2. charcot joint: pt was placed in a frame and dressing changes done per podiatry. he was started on cefazolin and transitioned to keflex po. he will complete a two week course of keflex. pain was well controlled w/percocet prn. pt was cleared by podiatry on day of discharge and provided with crutches. pt was instructed to follow up w/podiatry within 5 days of discharge for close wound monitoring. no signs of infection throughout his course. he had a low grade temp 100.3 on post op but remained afebrile for 48hours prior to discharge. pt was sent home w/good bowel regimen given narcotics for pain control. pt was also started on asa for ppx given recent surgery and somewhat limited mobility. . 3. hypertension: pt was re-started on lisinopril and continued on norvasc. . #. code: full . medications on admission: androgel 1% qd to shoulder asa 81 qd atorvastatin 10 qd caverject 20 mcg qd prn humalog 6 u tid lantus 35 u q pm lisinopril 40 qd metoprolol succ 100 qd norvasc 10 qd spironolactone 50 mg qd discharge medications: 1. oxycodone-acetaminophen 5-325 mg tablet sig: one (1) tablet po q4-6h (every 4 to 6 hours) as needed for 2 weeks. disp:*60 tablet(s)* refills:*0* 2. amlodipine 5 mg tablet sig: one (1) tablet po daily (daily). 3. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day) for 2 weeks. disp:*30 capsule(s)* refills:*0* 4. metformin 500 mg tablet sig: two (2) tablet po bid (2 times a day). disp:*120 tablet(s)* refills:*2* 5. atorvastatin 10 mg tablet sig: one (1) tablet po daily (daily). 6. lisinopril 10 mg tablet sig: one (1) tablet po daily (daily). disp:*30 tablet(s)* refills:*2* 7. cephalexin 500 mg capsule sig: one (1) capsule po q6h (every 6 hours) for 12 days. disp:*48 capsule(s)* refills:*0* 8. senna 8.6 mg tablet sig: one (1) tablet po bid (2 times a day) for 2 weeks. disp:*28 tablet(s)* refills:*0* 9. bisacodyl 5 mg tablet, delayed release (e.c.) sig: two (2) tablet, delayed release (e.c.) po daily (daily) for 2 weeks. disp:*30 tablet, delayed release (e.c.)(s)* refills:*0* 10. aspirin 325 mg tablet sig: one (1) tablet po daily (daily). 11. insulin glargine 100 unit/ml solution sig: one (1) subcutaneous qam: please take 50u glargine at breakfast-daily. disp:*1 vial* refills:*2* 12. insulin lispro (human) 100 unit/ml solution sig: one (1) subcutaneous three times a day: please use per scale. disp:*1 vial* refills:*2* discharge disposition: home discharge diagnosis: diabetes charcot joint s/p intra-op repair hyperglycemia hypertension discharge condition: stable discharge instructions: continue to take all your medications as directed. . you need to continue keflex, antibiotic for two weeks and see podiatry in clinic next week. . if you notice fevers, increasing pain not relieved by your pain medication, or significant bleeding please call your podiatrist/surgeon or go to the emergency room. . you may do touch-down weight bearing of your right foot. followup instructions: please call clinic on tuesday for a follow up appointment next week. . please call your primary care physician, . at for a follow up appointment in weeks. procedure: application of external fixator device, tibia and fibula transfusion of packed cells other change in muscle or tendon length other fusion of foot application of external fixator device, ring system limb lengthening procedures, tibia and fibula diagnoses: unspecified essential hypertension acute posthemorrhagic anemia polyneuropathy in diabetes peripheral vascular disease, unspecified chronic viral hepatitis b without mention of hepatic coma without mention of hepatitis delta diabetes with neurological manifestations, type ii or unspecified type, uncontrolled arthropathy associated with neurological disorders 

Answer: The patient is high likely exposed to